An exploration of what clones are, how they are made, and their role in cannabis genetics

The municipality of Minas Gerais will acquire, through electronic bidding, cannabis-based medication to treat a patient with a rare genetic syndrome.

Mimosa, created by Symbiotic Genetics, has become a landmark in the cannabis industry with its citrus profile and high demand

This is the moment to take care of drying and curing — stages that turn the harvest into an experience and learning process

Experts explain how cannabinoids, terpenes, and flavonoids vary from one species to another of the plant and how this contributes to individualized treatment

From the stimulating effects of Malawi Gold to the resins of the Rif in Morocco, the African continent has profoundly influenced the development of many cannabis varieties.

Cannabis patient cultivates and produces his treatment and his father's; results are surprising, according to Celso Murilo

If the products were more affordable, it would be possible to analyze the exact compounds in the oils and offer a more effective treatment to patients

The experiment aims to expose plants to microgravity for nine months following a capsule recovery failure in 2025

A group of 58 specialists from public and private universities advocates for evidence-based regulations for the cultivation and regulation of cannabis in Brazil

Technical-scientific agreement aims to boost innovation, regulation, and safe access to plant derivatives in Brazil

Bedrocan has started distributing its most potent medicinal cannabis flower in Germany, with 25% THC, expanding the options available in the country's regulated market

Recent studies highlight THC and CBN as key cannabinoids that may assist in treating the condition

Unveiling the symptoms, consequences, and benefits of cannabis in treating the disease

An analysis of the medicinal use of cannabis in managing the condition

The first study is being conducted in partnership with an association in Santa Maria, Rio Grande do Sul

Isolated CBD cannabidiol helps combat the immune response of vitiligo with an improvement of 16.7% in three weeks

Companies located in Argentina, Chile, Uruguay, and the United States are facing a new type of crime: the theft of cannabis plants. Pablo Fazio discusses the risks of this new trend in his column.

The safety and efficacy of cannabis-based products depend on an integrated chain involving chemists, biomedicals, pharmacists, and doctors — professionals who ensure, at each stage, the quality, stability, and trust in patient treatment

Proposal authorizes companies to cultivate plants with up to 0.3% THC exclusively for the production of medicinal inputs, but experts warn of the technical unfeasibility of the limit in a tropical climate